|
COMMD8 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.65580000003274E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.76599999962757E-07 |
| Normal-vs-Stage2 |
1.723360E-03 |
| Normal-vs-Stage3 |
1.022860E-04 |
| Normal-vs-Stage4 |
6.102000E-01 |
| Stage1-vs-Stage2 |
7.179200E-01 |
| Stage1-vs-Stage3 |
4.873400E-01 |
| Stage1-vs-Stage4 |
3.434800E-01 |
| Stage2-vs-Stage3 |
3.682000E-01 |
| Stage2-vs-Stage4 |
4.547400E-01 |
| Stage3-vs-Stage4 |
2.361200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.40589999975127E-07 |
| Normal-vs-AfricanAmerican |
4.26190000002435E-06 |
| Normal-vs-Asian |
6.178400E-01 |
| Caucasian-vs-AfricanAmerican |
8.416200E-01 |
| Caucasian-vs-Asian |
6.397200E-01 |
| AfricanAmerican-vs-Asian |
6.162200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.72340000048621E-07 |
| Normal-vs-Female |
4.01189999998941E-07 |
| Male-vs-Female |
7.220000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.973700E-04 |
| Normal-vs-Extreme_Weight |
2.66070000032315E-07 |
| Normal-vs-Obese |
2.397200E-04 |
| Normal-vs-Extreme_Obese |
2.532000E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.406600E-01 |
| Normal_Weight-vs-Obese |
8.646000E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.636600E-01 |
| Extreme_Weight-vs-Obese |
8.235000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.523000E-01 |
| Obese-vs-Extreme_Obese |
5.727400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.82909999999681E-05 |
| Normal-vs-Age(41-60Yrs) |
1.47730000010782E-07 |
| Normal-vs-Age(61-80Yrs) |
4.41480000001881E-06 |
| Normal-vs-Age(81-100Yrs) |
1.58456000000085E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.878200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.135800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.886600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.348000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.837000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.467760E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.88889999974684E-07 |
| Normal-VS-Type2 PRCC |
5.057100E-03 |
| Normal-VS-KIRP CIMP |
2.03690000422085E-08 |
| Normal-VS-Unclassified PRCC |
4.28809999997171E-06 |
| Type1 PRCC-VS-Type2 PRCC |
4.875000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.127630E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.913600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.357670E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
2.787200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.930500E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.58289999999217E-06 |
| Normal-vs-N1 |
1.17889999995402E-06 |
| Normal-vs-N2 |
3.72130000000359E-05 |
| N0-vs-N1 |
6.730600E-01 |
| N0-vs-N2 |
2.073800E-01 |
| N1-vs-N2 |
1.735980E-01 |
|
|
